Over the past 30 years, many molecular genetic mechanisms underlying motor
neuron diseases (MNDs) have been discovered and studied. Among these diseases,
amyotrophic lateral sclerosis (ALS), which causes the progressive degeneration
and death of central and peripheral motor neurons, and spinal muscular atrophy
(SMA), which is one of the inherited diseases that prevail among hereditary
diseases in the pattern of child mortality, hold a special place. These
diseases, like most nerve, neurodegenerative, and psychiatric diseases, cannot
be treated appropriately at present. Artificial model systems, especially those
that are based on the use of embryonic stem cells (ESCs) and induced
pluripotent stem cells (iPSCs), are of paramount importance in searching for
adequate therapeutic agents, as well as for a deep understanding of the MND
pathogenesis. This review is mainly focused on the recent advance in the
development of and research into cell and animal models of ALS and SMA. The
main issues concerning the use of cellular technologies in biomedical
applications are also described.